AmyPEarlyMDFACP

PubMed

• Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
  Muhammad Awidi, Angel Mier-Hicks, Stuthi Perimbeti, Kristopher Attwood, Hongbin Chen
  Clinical Lung Cancer. 2024-09-01
• 7 citations
  Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.
  Shipra Gandhi, Mateusz Opyrchal, Melissa J Grimm, Ronald T Slomba, Kathleen M Kokolus
  Journal for Immunotherapy of Cancer. 2023-11-01
• 3 citations
  Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study.
  Maithreyi Sarma, Stuthi Perimbeti, Samar Nasir, Kristopher Attwood, Ankita Kapoor
  Breast Cancer Research and Treatment. 2022-04-01

Abstracts/Posters

• Immune Subsets by GI Tumor Type
  Early A, Pabla S, Conroy JM, Nesline MK, Glenn S, Papanicolau-Sengos A, Burgher B, Giamo V, Andreas J, DePietro P, Lenzo F,Wang Y, Morrison C, Society for Immunotherapy of Cancer 33rd Annual Meeting, Washington, DC, 11/9/2018

Lectures

• Immunotherapy and Targeted Therapy for Cancer of the Lung. City-Wide Grand Rounds 
  Jacobs Schoold of Medicine & Biomedical Sciences - 9/14/2017
• : Clinical Impact of Genomic Sequencing in Cancer of the Lung 
  Louisianna State University School of Medicine - 11/18/2016
• Early AP: Plenary Session. The Obesity Epidemic: Impact on Breast Cancer and Survivorship. National Consortium of Breast Centers Annual Interdisciplinary Breast Ce... 
• Early AP: Management of the Axilla while Minimizing Morbidity-The Roles of Surgery, Radiation, Systemic Therapy & Observation. National Consortium of Breast Cancers ... 
  3/14/2015
• Update on HER2+ Breast Cancer (Early & Advanced Stage) in 2015. Annual Interdisciplinary Breast Center Conference 
  Las Vegas, NV - 2/15/2015
• Join now to see all